Real-World Experience Using Bimekizumab for the Treatment of Moderate-to-Severe Psoriasis From a Single Outpatient Dermatology Clinic

被引：3
|
作者：
Cirone, Katrina D. [1 ]
Lovegrove, Fiona E. [1 ,2 ,3 ]
机构：
[1] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[2] Lovegrove Dermatol, London, ON, Canada
[3] Lovegrove Dermatol, 207-140 Oxford St East, London, ON, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2024年 / 28卷 / 01期
关键词：
bimekizumab; psoriasis; biological therapy; real-world data; systemic therapy; SEVERE PLAQUE PSORIASIS; DOUBLE-BLIND; MULTICENTER; EFFICACY; SAFETY;
D O I：
10.1177/12034754231217205
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics
    Mortato, E.
    Artosi, F.
    Borselli, C.
    Compagnucci, I.
    Rivieccio, Antonia
    Lanna, C.
    Lambiase, S.
    Gaeta Shumak, R.
    Loconsole, F.
    Bianchi, L.
    Campione, E.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [2] Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis
    Wong, T. H.
    Sinclair, S.
    Smith, B.
    Fraser, C.
    Morton, C. A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (06) : 675 - 676
  • [3] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [4] Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry
    Strober, Bruce
    Ferris, Laura
    Duffin, Kristina Callis
    Janak, Jud C.
    Sima, Adam P.
    Eckmann, Thomas
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Armstrong, April
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 82 - 90
  • [5] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [6] Comparison of the disease survival of biologics for the treatment of moderate-to-severe psoriasis: real-world data
    Oh, S-M
    Kang, K-W
    Kang, D-H
    Kwon, S-H
    Lew, B-L
    Shin, M. K.
    Jeong, K-H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S343 - S343
  • [7] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    He Huang
    Ming-Long Cai
    Xiao-Jie Hong
    Li-Jun Zheng
    Zhu-Lin Hu
    Tao Yuan
    Wei-Ran Li
    Yu-Jun Sheng
    Xue-Jun Zhang
    European Journal of Dermatology, 2020, 30 : 554 - 560
  • [8] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [9] Risankizumab for the treatment of moderate-to-severe psoriasis: Real-world data from the Czech Republic BIOREP Registry
    Kojanova, Martina
    Fialova, Jorga
    Cetkovska, Petra
    Gkalpakiotis, Spyridon
    Machovcova, Alena
    Arenberger, Petr
    Stork, Jiri
    Dolezal, Tomas
    Strosova, Daniela
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB83 - AB83
  • [10] Real-world evidence of oral roflumilast in patients with moderate-to-severe psoriasis
    Gyldenlove, Mette
    Nissen, Christoffer Valdemar
    Stave, Sascha Dinsen Wreschner
    Thomsen, Simon Francis
    Egeberg, Alexander
    Loft, Nikolai
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
12345